History:

Azithromycin and Coronary Events Study

ACES is a clinical trial sponsored by the National Heart, Lung and Blood Institute. It is being conducted in more than 25 sites with enroll 4,000 volunteer patients.

History:

Some studies suggest that Chlamydia pneumoniae infection may be a risk factor for heart attacks and other conditions related to heart disease. This bacteria is spread person to person by sneezing and coughing (unlike a related bacteria, Chlamydia trachomatis, it is not a sexually transmitted disease). Studies show that people who have been infected with Chlamydia pneumoniae in the past have a higher chance of having a heart attack.

Subjects needed:

Anyone with a history of a heart attack, bypass surgery, angioplasty, or a 50% or greater blockage in a coronary artery is eligible for an interview for the ACES Study with their cardiologist's permission.

Call Ed Mackler, RN, at 401-793-4795, or beep him at 401-785-6331 for a phone interview.